Reviews of RE104 (luvesilocin) – 4-OH-DiPT prodrug
No reviews yet. Share the first one.
RE104 (luvesilocin) – 4-OH-DiPT prodrug by Reunion Neuroscience, Inc.
This investigational candidate is being studied in Phase 2 for postpartum depression; a Phase 3 trial was planned for 2026. Investigational; not for sale.
Guides about RE104 (luvesilocin) – 4-OH-DiPT prodrug